carbogen has been researched along with Astrocytoma, Grade IV in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boss, A; Kuhn, FP; Nanz, D; Özbay, PS; Pruessmann, KP; Riesterer, O; Rossi, C; Stieb, S; Weiss, T | 1 |
Bernaudin, M; Chakhoyan, A; Chazaviel, L; Corroyer-Dulmont, A; Delcroix, N; Divoux, D; Gérault, A; Kauffmann, F; Leblond, MM; MacKenzie, ET; Petit, E; Toutain, J; Touzani, O; Valable, S | 1 |
Clusmann, H; Dahnke, H; Flacke, S; Gieseke, J; König, R; Kovacs, A; Müller, A; Mürtz, P; Remmele, S; Schild, HH; Soehle, M; Träber, F; Wenningmann, I; Willinek, WA | 1 |
Clusmann, H; Flacke, S; Gieseke, J; König, R; Müller, A; Mürtz, P; Remmele, S; Schild, HH; Träber, F; Wenningmann, I; Willinek, WA | 1 |
Baillet, F; Chiras, J; Delattre, JY; Hoang-Xuan, K; Mazeron, JJ; Noël, G; Simon, JM | 1 |
Fitzek, C; Hochstetter, A; Kaiser, WA; Kalff, R; Rauscher, A; Reichenbach, JR; Sedlacik, J; Walter, B | 1 |
Bernsen, HJ; Bussink, J; Peeters, W; Schuuring, J; van der Kogel, AJ | 1 |
Caciagli, P; Cartei, F; Ducci, F; Fatigante, L; Laddaga, M; Marini, C; Prediletto, R | 1 |
Duncan, GG; Graham, P; Green, A; Marlow, C; Pickles, T; Rheaume, DE; Syndikus, I | 1 |
Caciagli, P; Cartei, F; Colosimo, S; Danesi, R; Del Tacca, M; Ducci, F; Fatigante, L; Laddaga, M; Marini, C; Prediletto, R | 1 |
Horsman, MR | 1 |
Horsman, MR; Knühmann, K; Sack, H; Stüben, G; Stuschke, M | 1 |
Booij, J; Bosch, DA; González González, D; Hulshof, MC; Rehmann, CJ; van Royen, EA | 1 |
Bernier, J; Bolla, M; Denekamp, J; Greiner, R; Hulshof, M; Miralbell, R; Mirimanoff, RO; Mornex, F; Pierart, M; Rojas, AM; Storme, G; van Glabbeke, M | 1 |
Buchegger, F; Coucke, PA; Mirimanoff, RO; Sun, LQ | 1 |
5 trial(s) available for carbogen and Astrocytoma, Grade IV
Article | Year |
---|---|
Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
Topics: Adult; Aged; Biopsy; Brain; Brain Neoplasms; Carbon Dioxide; Chi-Square Distribution; Combined Modality Therapy; Computer Graphics; Drug Therapy, Combination; Female; Glioblastoma; Humans; Male; Middle Aged; Niacinamide; Oxygen; Proportional Hazards Models; Radiation-Sensitizing Agents; Retrospective Studies; Statistics, Nonparametric; Survival Analysis | 2003 |
High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent.
Topics: Adult; Astrocytoma; Brain Neoplasms; Carbon Dioxide; Contrast Media; Female; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen | 2005 |
Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Animals; Carbon Dioxide; Combined Modality Therapy; Drug Tolerance; Female; Glioblastoma; Humans; Liver; Male; Middle Aged; Niacinamide; Oxygen; Prospective Studies; Radiotherapy Dosage; Rats; Treatment Outcome | 1996 |
Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.
Topics: Analysis of Variance; Brain Neoplasms; Carbon Dioxide; Cell Hypoxia; Cerebrovascular Circulation; Glioblastoma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Radiopharmaceuticals; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1998 |
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Brain Neoplasms; Carbon Dioxide; Cell Division; Cell Hypoxia; Dose Fractionation, Radiation; Female; Glioblastoma; Humans; Male; Middle Aged; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Survival Analysis; Treatment Outcome | 1999 |
10 other study(ies) available for carbogen and Astrocytoma, Grade IV
Article | Year |
---|---|
Lesion magnetic susceptibility response to hyperoxic challenge: A biomarker for malignant brain tumor microenvironment?
Topics: Adult; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Carbon Dioxide; Female; Glioblastoma; Humans; Hypercapnia; Hyperoxia; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Oxygen; Prospective Studies; Tumor Microenvironment | 2018 |
Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.
Topics: Animals; Brain Neoplasms; Carbon Dioxide; Cerebrovascular Circulation; Glioblastoma; Humans; Magnetic Resonance Imaging; Oxygen; Rats, Nude; Xenograft Model Antitumor Assays | 2017 |
Quantification of the magnetic resonance signal response to dynamic (C)O(2)-enhanced imaging in the brain at 3 T: R*(2) BOLD vs. balanced SSFP.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carbon Dioxide; Diagnostic Imaging; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Oxygen; Sensitivity and Specificity; Time Factors | 2010 |
Intracranial tumor response to respiratory challenges at 3.0 T: impact of different methods to quantify changes in the MR relaxation rate R2*.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carbon Dioxide; Echo-Planar Imaging; Female; Glioblastoma; Humans; Hypercapnia; Hyperoxia; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Oxygen; Respiration; Sensitivity and Specificity | 2010 |
Effect of carbogen breathing on the radiation response of a human glioblastoma xenograft: analysis of hypoxia and vascular parameters of regrowing tumors.
Topics: Animals; Carbon Dioxide; Glioblastoma; Humans; Hypoxia; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Oxygen; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2006 |
Carbogen breathing in patients with glioblastoma multiforme submitted to radiotherapy. Assessment of gas exchange parameters.
Topics: Administration, Inhalation; Adult; Aged; Blood Gas Analysis; Brain Neoplasms; Carbon Dioxide; Female; Glioblastoma; Humans; Male; Middle Aged; Oxygen; Pulmonary Gas Exchange; Radiation-Sensitizing Agents | 1994 |
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
Topics: Administration, Inhalation; Adult; Aged; Carbon Dioxide; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate | 1997 |
Tolerance to nicotinamide and carbogen with radiation therapy for glioblastoma.
Topics: Carbon Dioxide; Glioblastoma; Humans; Niacinamide; Oxygen; Radiation-Sensitizing Agents | 1997 |
The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Cell Hypoxia; Drug Combinations; Glioblastoma; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neurofibrosarcoma; Niacinamide; Oxygen; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sarcoma; Sarcoma, Experimental; Skin Neoplasms; Transplantation, Heterologous | 1998 |
Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
Topics: Administration, Inhalation; Animals; Brain Neoplasms; Carbon Dioxide; Cell Division; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Therapy, Combination; Female; Glioblastoma; Humans; Mice; Mice, Nude; Niacinamide; Oxygen; Radiation Injuries, Experimental; Radiation-Sensitizing Agents; Skin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |